Table 4 The sensitivity analysis at 45% sharing rate for marginal annual cost saving, cost - effectiveness and cost – benefit of SIF in Montreal
Variables | Annual cost of operation | Sharing rate | # of HIV averted | # of HCV averted | HIV cost saved | HCV cost saved | Cost-effectiveness ratio HCV | Cost-effectiveness ratio HIV | Cost-benefit ratio HCV | Cost-benefit ratio HIV |
|---|---|---|---|---|---|---|---|---|---|---|
Post SIF | $2,182,800 | 45% | 19 | 115 | $1,817,745 | $1,858,645 | $18,980 | $114,884 | 1.85 | 1.8 |
Two SIF | $2,182,800 | 35% | 16 | 99 | $1,186,080 | $1,296,357 | $22,048 | $136,425 | 1.6 | 1.5 |
Three SIF | $2,182,800 | 27% | 7 | 43 | -$708,915 | -$671,651 | $50,763 | $311,829 | 0.7 | 0.68 |
Four SIF | $2,182,800 | 23% | 7 | 43 | -$708,915 | -$671,651 | $50,763 | $311,829 | 0.7 | 0.68 |
Five SIF | $2,182,800 | 20% | 7 | 43 | -$708,915 | -$671,651 | $50,763 | $311,829 | 0.7 | 0.68 |
Six SIF | $2,182,800 | 16.00% | 7 | 43 | -$708,915 | -$671,651 | $50,763 | $311,829 | 0.7 | 0.68 |
Seven SIF | $2,182,800 | 12% | 7 | 43 | -$708,915 | -$671,651 | $50,763 | $311,829 | 0.7 | 0.68 |
Average | $2,182,800 | 9% | 10 | 61 | -$540,750 | -$203,253 | $42,120 | $258,636 | 1 | 0.95 |